Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47,144,064
-
Total 13F shares
-
32,977,477
-
Share change
-
+1,978,856
-
Total reported value
-
$79,245,821
-
Price per share
-
$2.42
-
Number of holders
-
47
-
Value change
-
+$5,008,841
-
Number of buys
-
20
-
Number of sells
-
10
Institutional Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q4 2025
As of 31 Dec 2025,
Whitehawk Therapeutics, Inc. - Common stock (WHWK) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,977,477 shares.
The largest 10 holders included
QVT Financial LP, ORBIMED ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, ACUTA CAPITAL PARTNERS, LLC, Avoro Capital Advisors LLC, KVP Capital Advisors, LP, Siren, L.L.C., Yu Fan, VANGUARD GROUP INC, and STEMPOINT CAPITAL LP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.